Macrophage inflammatory protein-3 alpha (MIP-3a) Is a novel serum prognostic marker in patients with colorectal cancer

Changing Management and Survival in Patients With Stage IV Colorectal Cancer

(2011) Cameron Platell et al.   DISEASES OF THE COLON & RECTUM

Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009

(2010) R. Adam et al.   ANNALS OF ONCOLOGY

Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status

(2010) D J Watkins et al.   BRITISH JOURNAL OF CANCER

Integration of Host-Related Signatures with Cancer Cell-Derived Predictors for the Optimal Management of Anticancer Chemotherapy

(2010) L. Zitvogel et al.   CANCER RESEARCH

CCL20/CCR6 expression profile in pancreatic cancer

(2010) Claudia Rubie et al.   Journal of Translational Medicine

Colorectal cancer

(2010) David Cunningham et al.   LANCET

Metastatic Colorectal Cancer: From Improved Survival to Potential Cure

(2010) David J. Gallagher et al.   ONCOLOGY

Systematic Review of Prognostic Factors Related to Overall Survival in Patients with Stage IV Colorectal Cancer and Unresectable Metastases

(2010) Andrew P. Stillwell et al.   WORLD JOURNAL OF SURGERY

Treatment in advanced colorectal cancer: what, when and how?

(2009) I Chau et al.   BRITISH JOURNAL OF CANCER

The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer

(2009) Pirus Ghadjar et al.   INTERNATIONAL JOURNAL OF CANCER

Macrophage Inflammatory Protein-3  Is a Novel Serum Marker for Nasopharyngeal Carcinoma Detection and Prediction of Treatment Outcomes

(2008) K.-P. Chang et al.   CLINICAL CANCER RESEARCH

Prognostic versus predictive value of biomarkers in oncology

(2008) C.N.A.M. Oldenhuis et al.   EUROPEAN JOURNAL OF CANCER

Urgent Need for a New Staging System in Advanced Colorectal Cancer

(2008) Graeme J. Poston et al.   JOURNAL OF CLINICAL ONCOLOGY